Cetuximab-MMAE (ADC)
Cetuximab-MMAE is an ADC consisting of an EGFR-directed antibody and Monomethyl auristatin E (MMAE) used for the study of colorectal cancer and head and neck cancer.
Product Specifications
Reactivity
Human
Applications
Research Grade Biosimilar
Stability
Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks) . Store at -20°C 12 months. Store at -80°C long term.
Endotoxin
Please contact with the lab for this information.
Purity
>90% as determined by SEC.
Form
Liquid
Notes
For research use only. Not suitable for clinical or therapeutic use.
More Discoveries
Explore Other Products
Browse additional items from our catalog
